Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:2465-2473

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dart, A. M.
Right arrow Articles by Cooper, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dart, A. M.
Right arrow Articles by Cooper, B.
Related Collections
Right arrow Nutrition
Right arrow Lipid and lipoprotein metabolism
Right arrow Risk Factors
Right arrow Genomics
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:2465-2473.)
© 1999 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Independent Effects of Apo E Phenotype and Plasma Triglyceride on Lipoprotein Particle Sizes in the Fasting and Postprandial States

Anthony M. Dart; Bridget Cooper
Abstract—LDL particle sizes and Apo E phenotypes were determined in 212 subjects of whom 51 had angina. LDL diameter was significantly less in subjects with an {epsilon}2 allele (24.76±0.08 vs 24.94±0.02 nm, P=0.02), and this was evident for both E2/E3 (24.77±0.09 nm) and E2/E4 (24.69±0.08 nm) phenotypes. Although there was a negative relation between LDL diameter and plasma triglyceride, the effect of apo E2 was still evident with adjustment for triglyceride. In multiple regression analysis, the significant determinants of LDL diameter were gender (with females having larger particles than males), body mass index, and the presence (or absence) of E2. HDL particle sizes and compositions were determined on fasting samples and, additionally, 5 and 8 hours after a fat-rich meal for 48 coronary heart disease cases and 49 control subjects. Fasting HDL particle sizes were not related to the presence of E2 but were significantly smaller for subjects possessing an {epsilon}4 allele (8.09±0.08 vs 8.39±0.05 nm, P=0.003) and were negatively related to plasma triglyceride. However, the effect of E4 persisted after adjustment for triglyceride. In a multiple regression analysis, the only significant determinant of fasting HDL diameter was the presence (or absence) of E4 with fasting plasma triglyceride just failing to reach significance (P=0.06). There was a postprandial increase in HDL diameter that was less marked in subjects with coronary heart disease. The postprandial increase in HDL diameter was of sufficient magnitude to result in size reclassification of HDL particles. The influence of E4 was also evident at both postprandial time points. Compositional analysis demonstrated that the increase in HDL diameters postprandially could be attributed to triglyceride enrichment, with an accompanying fall in cholesterol ester content. Phospholipid changes postprandially were biphasic with an initial fall followed by a rise in concentration. The increase in triglyceride content was significantly less in those subjects with angina despite an equivalent rise in plasma triglyceride. The present study demonstrates significant, but different, effects of variation in apo E phenotype on the particle sizes of both HDL and LDL. Such effects were still evident with adjustment for differences in plasma triglyceride and suggests that variation in apo E phenotype exerts effects on lipoprotein particle sizes by mechanisms additional to those dependent on change in plasma triglyceride.


Key Words: apo E • LDL particle size • HDL particle size • triglyceride • coronary heart disease • postprandial




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. M. Krauss
Dietary and Genetic Probes of Atherogenic Dyslipidemia
Arterioscler. Thromb. Vasc. Biol., November 1, 2005; 25(11): 2265 - 2272.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. A. Moreno, F. Perez-Jimenez, C. Marin, P. Gomez, P. Perez-Martinez, R. Moreno, C. Bellido, F. Fuentes, and J. Lopez-Miranda
The Effect of Dietary Fat on LDL Size Is Influenced by Apolipoprotein E Genotype in Healthy Subjects
J. Nutr., October 1, 2004; 134(10): 2517 - 2522.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Y. Bosse, L. Perusse, and M.-C. Vohl
Genetics of LDL particle heterogeneity: from genetic epidemiology to DNA-based variations
J. Lipid Res., June 1, 2004; 45(6): 1008 - 1026.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Bosse, L. Perusse, J.-P. Despres, B. Lamarche, Y. C. Chagnon, T. Rice, D.C. Rao, C. Bouchard, and M.-C. Vohl
Evidence for a Major Quantitative Trait Locus on Chromosome 17q21 Affecting Low-Density Lipoprotein Peak Particle Diameter
Circulation, May 13, 2003; 107(18): 2361 - 2368.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. J. Hockey, R. A. Anderson, V. R. Cook, R. R. Hantgan, and R. B. Weinberg
Effect of the apolipoprotein A-IV Q360H polymorphism on postprandial plasma triglyceride clearance
J. Lipid Res., February 1, 2001; 42(2): 211 - 217.
[Abstract] [Full Text]